UK experts are calling for greater consideration of gastric banding as an option for obese people with type 2 diabetes who need to lose weight. Dr Jonathan Pinkney, diabetologist, and Mr Paul Super, obesity surgeon, initiated this call to action following the recent European label change confirming that weight loss with Allergan's LAP-BAND [TM] AP System can lead to improvement or remission of type 2 diabetes. The risk of developing type 2 diabetes is increased up to 10 times in obese people and, alarmingly, the UK has the fastest growing rate of obesity in the developed world. The recent decision by TUV SUD - a European Union notified body responsible for the certification of medical devices - recognises the LAP-BAND [TM] AP System as the first obesity intervention device in Europe to be officially approved for its effect on type 2 diabetes in obese patients through weight loss.
A UK consumer watchdog that is campaiging for clearer food labelling analysed a selection of pre-packed salads from high street supermarkets and found that while many provided the recommended "5 a day", they varied widely in the amount of calories, fat and salt they contained, and one in particular had more calories and fat than a "Big Mac". Product-testing and consumer rights group Which? analysed 20 pre-packed salalds they bought from Asda, Boots, Marks & Spencer, Morrisons, Sainsbury's, Tesco and Waitrose and discovered that Smedleys Atlantic Prawn Marie Rose Salad, for sale at Â 1.49 for a 300g pack at Morrisons, "contained 855 calories and 66.
Surgeons Use USGI Medical's Incisionless Operating Platform To Reduce Pouch, Stoma Size In Gastric Bypass Patients
New data show that surgeons can use USGI Medical Inc.'s (USGI) Incisionless Operating Platform(TM) (IOP) to durably reduce the size of the stomach pouch and stoma in Roux-en-Y Gastric Bypass (RYGB) patients who are regaining weight because this portion of their anatomy has stretched since their original surgery. On Friday, June 26 at the American Society of Metabolic and Bariatric Surgeons (ASMBS) Annual Meeting near Dallas, University of California, San Diego (UCSD) Medical Center surgeon Santiago Horgan, M.D. presented outcomes from 116 patients who underwent this incisionless procedure to reduce the size of their pouch and stoma. "We believe this is the first data to confirm 12-month durability for gastric folds created without incisions, " said Dr.
A Fresh Start To Summer; New Program Offers Personalized Physician-assisted Approach To Losing Weight
Perhaps the only thing harder than sticking to a weight loss plan is starting a new one after yet another failed diet attempt. Physicians Sharon Herring and Stephanie Ward recognize such "diet fatigue" in their patients and their own families. Now, they're offering a "fresh start" to the diet-weary. Temple's "Fresh Start to a Healthy Weight, " is designed to promote healthy behaviors such as physical activity and better food choices and prevent and treat adult obesity through one-on-one counseling. An extension of the General Internal Medicine Practices at Temple, the program opens in July. "We know that when patients engage with providers who are solely focused on weight loss issues, they lose weight so that's what we plan to do, " said Sharon Herring, MD, MPH, Assistant Professor of Medicine and Public Health at Temple University's Center for Obesity Research and Education.
Elevated insulin levels in the blood appear to raise the risk of breast cancer in postmenopausal women, according to researchers at Albert Einstein College of Medicine of Yeshiva University. Their findings are published in the online version of the International Journal of Cancer. Increased breast cancer risk for postmenopausal women has previously been linked to obesity and diabetes. Both conditions involve insulin resistance, which causes increases in circulating levels of insulin. Since insulin is known to promote cell division and enhance breast tumor growth in animal models, the Einstein scientists reasoned that relatively high insulin levels may contribute to breast cancer risk in women.
Inpatients at Southampton's teaching hospitals are to be offered advice on lifestyle and weight management as part of a radical new project. Southampton University Hospitals NHS Trust's pharmacy team has invented an innovative plan to tackle obesity during routine risk assessments for venous thromboembolism (VTE), better known as blood clots. All patients admitted to hospital are susceptible to VTE, which causes an estimated 25, 000 preventable deaths per year in England, so safety reviews are now carried out on all inpatients. Pharmacists conduct these assessments and identify risk factors, such as obesity, that can cause fatal clots. SUHT is now developing a pilot project in collaboration with primary care services to expand the role of pharmacists, allowing them to advise patients about lifestyle and obesity management as opposed to just recording them as a VTE risk.